Kunming Biomed International
PrivateCompany Overview
Kunming Biomed International operates in Healthcare & Life Sciences and is based in Kunming. It was founded in 2006.
Kunming Biomed International is a contract research organization (CRO) that provides preclinical research services specializing in non-human primate (NHP) disease models for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kunming Biomed International Comparables
Compare Kunming Biomed International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prisys Biotechnology Co., Ltd. | 88% | |
| Virscio | 88% | |
| Cynbiose | 88% |
For institutional investors. Book with your work email.
Kunming Biomed International Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2023
Grew 36% QoQ, from 11 to 15 employees.
- Nov 15, 2023
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
Kunming Biomed International Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kunming Biomed International's valuation, stock price, and market status.
Is Kunming Biomed International a public or private company?
Kunming Biomed International is a private company.
What is the current stock price of Kunming Biomed International?
Kunming Biomed International is a private company, so its shares have no public market price. Caplight tracks Kunming Biomed International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kunming Biomed International worth (valuation)?
Valuation information for Kunming Biomed International is not publicly available.
Can I buy Kunming Biomed International stock?
Kunming Biomed International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kunming Biomed International's last funding round?
Funding round information for Kunming Biomed International is not publicly available.
Who are the main investors in Kunming Biomed International?
Investor information for Kunming Biomed International is not publicly disclosed.
Will Kunming Biomed International IPO soon?
No public IPO plans have been announced for Kunming Biomed International.
How can I track Kunming Biomed International secondary market activity?
Caplight tracks bids, offers, and trades in Kunming Biomed International's shares on secondary markets.